Ultrasensitive electrochemical detection of CYFRA 21-1 via in-situ initiated ROP signal amplification strategy - ScienceDirect
Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer | British Journal of Cancer
What is Cyfra 21-1 quantification? | Vinmec
Compensated Interferometry Measures of CYFRA 21–1 Improve Diagnosis of Lung Cancer | ACS Combinatorial Science
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer
Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing) DOI:10.1039/C9CC03620B
New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | SpringerLink
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - ScienceDirect
Cancers | Free Full-Text | Current and Prospective Protein Biomarkers of Lung Cancer
PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar
Frontiers | Diagnostic Value of Imaging Combined With Tumor Markers in Early Detection of Lung Cancer
CYFRA 21-1 - ABBOTT Diagnostics
Cyfra 21-1 Cancer Antigen
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma? | SpringerLink